Stay updated on AK002 in Allergic Conjunctivitis Clinical Trial
Sign up to get notified when there's something new on the AK002 in Allergic Conjunctivitis Clinical Trial page.

Latest updates to the AK002 in Allergic Conjunctivitis Clinical Trial page
- Check5 days agoChange Detected- Revision updated from v3.4.2 to v3.4.3. This reflects a minor page update with no changes to study details.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and the prior Revision: v3.4.1.SummaryDifference0.5%

- Check41 days agoChange DetectedA site-wide funding status notice was added, noting potential processing delays and that the NIH Clinical Center is open; the page also shows a software revision update to v3.4.1, replacing v3.4.0.SummaryDifference0.5%

- Check48 days agoChange DetectedAdded a glossary toggle and updated metadata to show 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while removing the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a Locations section listing California, Florida, Maryland, Massachusetts, Missouri, New Jersey, and Pennsylvania, and removed the corresponding state location sections. Footer revision note updated to Revision: v3.3.3 with v3.3.2 removed.SummaryDifference1.0%

Stay in the know with updates to AK002 in Allergic Conjunctivitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK002 in Allergic Conjunctivitis Clinical Trial page.